当前位置:首页>产品中心>单抗/多抗>Anti-Human Integrin beta 2 &Integrin alpha L/CD11a Bispecific Reference Antibody|抗人整合素β2和整合素αL/CD11a双特异性参考抗体(靶标:人CD11a/CD18(整合素αLβ2))

Anti-Human Integrin beta 2 &Integrin alpha L/CD11a Bispecific Reference Antibody|抗人整合素β2和整合素αL/CD11a双特异性参考抗体(靶标:人CD11a/CD18(整合素αLβ2))

  • 货号:RB9THY378026
  • 价格:面议
  • 点击:497

产品介绍

产品参数

形态Liquid
宿主种属Humanized
克隆性Monoclonal
抗体亚型IgG4-nd
纯度>95% as determined by SDS-PAGE.
纯化方式Protein A/G purified from cell culture supernatant.
浓度1 mg/ml
内毒素水平Please contact with the lab for this information.
应用ELISA, Bioactivity: FACS, Functional assay, Research in vivo
种属反应性Human
靶标Complement receptor C3 subunit beta, Cell surface adhesion glycoproteins LFA-1/CR3/p150, 95 subunit beta, Integrin beta-2, MFI7, CD18, ITGB2, CD11A, Leukocyte function-associated molecule 1 alpha chai
储存缓冲液0.01M PBS, pH 7.4.
稳定性和储存Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
表达系统Mammalian Cells
登录号P05107, P20701, P11215
背景信息Rovelizumab is a humanized monoclonal leukointegrin antibody. Rovelizumab is a monoclonal antibody directed against the CD11/CD18 cell adhesion proteins. Rovelizumab can be used for research of multiple sclerosis (MS), hemorrhagic shock, myocardial infarction (MI) and stroke.
别名Bispecific, Hu23F2G, 23F2G, 339086-79-2
种属Human
备注For research use only. Not suitable for clinical or therapeutic use.
【仅供科学研究使用】

相关产品:
总计 33037 个记录,共 1652 页,当前第 1 页 | 第一页 上一页 下一页 最末页
在线客服
  • 销售热线:
  • 15898894496(同微信)
  • 我要留言
  • 周一至周五每天9:00-17:00